Picture of Basilea Pharmaceutica AG, Allschwil logo

BSLN — Basilea Pharmaceutica AG, Allschwil News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

US FDA approves Basilea Pharmaceutica's antibiotic

April 3 (Reuters) - The U.S. health regulator approved
Basilea Pharmaceutica  BSLN.S  antibiotic for bacterial
infections including multidrug-resistant strains, the FDA said
on Wednesday.
    

 (Reporting by Sriparna Roy and Unnamalai L in Bengaluru;
Editing by Vijay Kishore)
 ((Sriparna.Roy@thomsonreuters.com;))

Recent news on Basilea Pharmaceutica AG, Allschwil

See all news